Novogen (NVGN)

Add to Watchlists
Create an Alert
2.31 -0.03  -1.28% NASDAQ Jan 29, 11:17AM BATS Real time Currency in USD
View Full Chart
NVGN Price Chart
View All Performance Charts

NVGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Novogen is down 43.10% over the last year vs S&P 500 Total Return up 14.34%, Auspex Pharmaceuticals up N/A, and Tetraphase Pharmaceutical up 128.1%.

Get Quote for

Portfolio Strategies Featuring NVGN

Did Novogen make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NVGN Profile

Novogen Ltd is in the early stage of drug development.

NVGN Excel Add-In Codes

  • Name: =YCI("NVGN","name")
  • Description: =YCI("NVGN","description")
  • Sector: =YCI("NVGN","sector")
  • Industry: =YCI("NVGN","industry")
  • Est. Current Fiscal Year End: =YCI("NVGN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 14 Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.